Is ischaemic modified albumin a marker in osteomyelitis patients?

Cihan Adanas, Sezai Ozkan, Canan Demir

JPMA. The Journal of the Pakistan Medical Association 2021 Feb

filter terms:

To compare the levels of ischaemia modified albu min between osteomyelitis patients and healthy controls. The cross-sectional prospective study was conducted at Van Yüzüncü Yıl University, Van, Turkey, from May 2018 to May 2019, and comprised inpatients diagnosed with osteomyelitis, and healthy controls. Serum IMA concentrations were determined spectrophotometrically at 470nm wavelength. Serum ischaemia modified albu min levels were measured and compared between the patients and the controls. Data was analysed using SPSS 20. Of the 77 subjects, 37(48%) were patients and 40(52%) were controls. Serum ischaemia modified albu min level in patients was significantly higher than controls (p<0.05). There was a significant correlation between ischaemia modified albumin and C-reactive protein levels (p<0.05). Serum ischaemia modified albu min level in patients was significantly higher than controls (p<0.05).

Citation

Cihan Adanas, Sezai Ozkan, Canan Demir. Is ischaemic modified albumin a marker in osteomyelitis patients? JPMA. The Journal of the Pakistan Medical Association. 2021 Feb;71(2(A)):461-464